These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 17197615)

  • 1. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities.
    ACOG Committee on Practice Bulletins
    Obstet Gynecol; 2007 Jan; 109(1):217-27. PubMed ID: 17197615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.
    Spencer K; Spencer CE; Power M; Dawson C; Nicolaides KH
    BJOG; 2003 Mar; 110(3):281-6. PubMed ID: 12628268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum analyte screening for fetal aneuploidy.
    Chasen ST
    Clin Obstet Gynecol; 2014 Mar; 57(1):182-8. PubMed ID: 24488056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new model for providing cell-free DNA and risk assessment for chromosome abnormalities in a public hospital setting.
    Wallerstein R; Jelks A; Garabedian MJ
    J Pregnancy; 2014; 2014():962720. PubMed ID: 25101177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second trimester ultrasound screening for chromosomal abnormalities.
    Shipp TD; Benacerraf BR
    Prenat Diagn; 2002 Apr; 22(4):296-307. PubMed ID: 11981910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities.
    Kagan KO; Sonek J; Wagner P; Hoopmann M
    Arch Gynecol Obstet; 2017 Oct; 296(4):645-651. PubMed ID: 28702698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions.
    Benn PA
    Clin Chim Acta; 2002 Oct; 324(1-2):1-11. PubMed ID: 12204419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial deletion of chromosome 7q and the lack of association with Down syndrome screening markers.
    Hafen LB; Rose NC
    Fetal Diagn Ther; 2010; 28(1):47. PubMed ID: 20587995
    [No Abstract]   [Full Text] [Related]  

  • 11. First trimester combined screening for fetal aneuploidies enhanced with additional ultrasound markers: an 8-year prospective study.
    Nemescu D; Bratie A; Mihaila A; Navolan D; Tanase A
    Ginekol Pol; 2018; 89(4):205-10. PubMed ID: 29781076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226.
    Obstet Gynecol; 2020 Oct; 136(4):859-867. PubMed ID: 32976375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.
    Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM
    J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2007 Dec; 110(6):1459-67. PubMed ID: 18055749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal second trimester screening for fetal chromosomal abnormalities as a predictor of adverse pregnancy outcome].
    Baś-Budecka E; Perenc M; Sieroszewski P
    Ginekol Pol; 2007 Nov; 78(11):877-80. PubMed ID: 18306921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226.
    ; ;
    Obstet Gynecol; 2020 Oct; 136(4):e48-e69. PubMed ID: 32804883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis for detection of aneuploidy: the options.
    Budorick NE; O'Boyle MK
    Radiol Clin North Am; 2003 Jul; 41(4):695-708. PubMed ID: 12899486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What are the real purpose and scope of screening for aneuploidy?].
    Quibel T; Rozenberg P
    Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.